Mike Morris โ€” investor profile photo

Mike Morris

Head of Genetics, SYNLAB Group

๐Ÿ“ Lausanne, Vaud, Switzerland๐Ÿ”„ Updated November 2026๐Ÿ’ผ 2 investments๐Ÿ“… 23 years investing๐Ÿ—“ Last invested Jan 2008
Angel investor๐ŸŒ Switzerland
2
Total investments
0
Early stage
0
Mid stage
1
Late stage
23y
Years active

Portfolio

1 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Board member
2003
The EMQN is a not-for-profit community interest company (CIC) promoting quality in diagnostic genomic testing through the provision of external quality assessment (proficiency testing schemes) and the organisation of best practice meetings and publication of guidelines. We are an internationally-respected, UKAS-accredited provider of External Quality Assessment (EQA) services, with 1600 members in 68 countries. EQA is an essential requirement for any laboratory seeking to provide a quality service and is a vital component of clinical governance. EMQN monitors global laboratory performance in diagnostic molecular genetics, molecular pathology, and technical laboratory testing processes such as DNA sequencing (Sanger and NGS). We are an ISO 17043 accredited EQA provider. To see our scope of accreditation, please go to http://www.ukas.com/wp-content/uploads/schedule_uploads/00013/4367Proficiency%20Testing%20Single.pdf. EMQN CIC is a company limited by guarantee and registered in England and Wales (Companies House Registration: 12020789). Our registered address is C/O Trustech, Citylabs 1.0, Nelson Street, Manchester, M13 9NQ, United Kingdom. Our physical address remains the same as before (see https://www.emqn.org/contact-us/).
Experience ยท 3 entries
All (3)
Investments (2)
Board (2)
2008
CSCQ
Board member
2008
2005
Partner
2005
EuroGentest2 is a Coordination Action funded by the 7th Framework of the European Commission. The project is organised in 3 Units looking at all aspects of genetic testing. The integration between Unit 1, 2 and 3 will be warranted by two transversal/cross-sectional work packages and one work package dedicated
2003
Board member
2003
The EMQN is a not-for-profit community interest company (CIC) promoting quality in diagnostic genomic testing through the provision of external quality assessment (proficiency testing schemes) and the organisation of best practice meetings and publication of guidelines. We are an internationally-respected, UKAS-accredited provider of External Quality Assessment (EQA) services, with 1600 members in 68 countries. EQA is an essential requirement for any laboratory seeking to provide a quality service and is a vital component of clinical governance. EMQN monitors global laboratory performance in diagnostic molecular genetics, molecular pathology, and technical laboratory testing processes such as DNA sequencing (Sanger and NGS). We are an ISO 17043 accredited EQA provider. To see our scope of accreditation, please go to http://www.ukas.com/wp-content/uploads/schedule_uploads/00013/4367Proficiency%20Testing%20Single.pdf. EMQN CIC is a company limited by guarantee and registered in England and Wales (Companies House Registration: 12020789). Our registered address is C/O Trustech, Citylabs 1.0, Nelson Street, Manchester, M13 9NQ, United Kingdom. Our physical address remains the same as before (see https://www.emqn.org/contact-us/).
Investor lists
Lists that match Mike's portfolio